These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7290095)

  • 1. DNA-cell-binding (DCB) assay for suspected carcinogens and mutagens.
    Kubinski H; Gutzke GE; Kubinski ZO
    Mutat Res; 1981 Jun; 89(2):95-136. PubMed ID: 7290095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased attachment of nucleic acids to eukaryotic and prokaryotic cells induced by chemical and physical carcinogens and mutagens.
    Kubinski H; Morin NR; Zeldin PE
    Cancer Res; 1976 Sep; 36(9 pt.1):3025-33. PubMed ID: 975072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species and strain differences in the hepatic cytochrome P450-mediated biotransformation of 1,4-dichlorobenzene.
    Hissink AM; Oudshoorn MJ; Van Ommen B; Van Bladeren PJ
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):1-9. PubMed ID: 9221818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of in vivo/in vitro unscheduled DNA synthesis for identification of organ-specific carcinogens.
    Furihata C; Matsushima T
    Crit Rev Toxicol; 1987; 17(3):245-77. PubMed ID: 3556021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of different pairs of DNA repair-deficient and DNA repair-proficient bacterial tester strains for rapid detection of chemical mutagens and carcinogens.
    Suter W; Jaeger I
    Mutat Res; 1982 Feb; 97(1):1-18. PubMed ID: 6799822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The detection of environmental mutagens and potential carcinogens.
    Ames BN
    Cancer; 1984 May; 53(10):2034-40. PubMed ID: 6367933
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP.
    Ashby J; Tennant RW
    Mutat Res; 1988 Jan; 204(1):17-115. PubMed ID: 3277047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the new system (umu-test) for the detection of environmental mutagens and carcinogens.
    Oda Y; Nakamura S; Oki I; Kato T; Shinagawa H
    Mutat Res; 1985 Oct; 147(5):219-29. PubMed ID: 3900709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Escherichia coli K12 inductest for detection of potential chemical carcinogens.
    Mamber SW; Bryson V; Katz SE
    Mutat Res; 1984 Jun; 130(3):141-51. PubMed ID: 6374442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro screening of carcinogens using DNA of the His- mutant of Salmonella typhimurium.
    Beljanski M; Le Goff L; Beljanski M
    Exp Cell Biol; 1982; 50(5):271-80. PubMed ID: 6754496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of a streamlined bacterial mutagenicity assay, the MINISCREEN.
    Brooks TM
    Mutagenesis; 1995 Sep; 10(5):447-8. PubMed ID: 8544759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 42 chemicals tested for carcinogenicity by the U.S. National Toxicology Program.
    Ashby J; Tennant RW; Zeiger E; Stasiewicz S
    Mutat Res; 1989 Jun; 223(2):73-103. PubMed ID: 2662004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of the correlation of bacterial mutagenicity with carcinogenicity of benzo(a)pyrene and four of its major metabolites by activation with intact liver cells instead of cell homogenate.
    Glatt HR; Billings R; Platt KL; Oesch F
    Cancer Res; 1981 Jan; 41(1):270-7. PubMed ID: 7448766
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of human hepatoma cells for in vitro metabolic activation of chemical mutagens/carcinogens.
    Natarajan AT; Darroudi F
    Mutagenesis; 1991 Sep; 6(5):399-403. PubMed ID: 1665540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prospects for a simplified and internationally harmonized approach to the detection of possible human carcinogens and mutagens.
    Ashby J
    Mutagenesis; 1986 Jan; 1(1):3-16. PubMed ID: 3325732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (groups 1, 2A and 2B) the summary report of the 6th collaborative study by CSGMT/JEMS MMS. Collaborative Study of the Micronucleus Group Test. Mammalian Mutagenicity Study Group.
    Morita T; Asano N; Awogi T; Sasaki YF; Sato S; Shimada H; Sutou S; Suzuki T; Wakata A; Sofuni T; Hayashi M
    Mutat Res; 1997 Feb; 389(1):3-122. PubMed ID: 9062586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of chemicals to mutagenic carcinogens by human hepatoma microsomal extracts in Chinese hamster ovary cells (in vitro).
    Darroudi F; Natarajan AT
    Mutagenesis; 1993 Jan; 8(1):11-5. PubMed ID: 8383795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenic activation of urinary bladder carcinogens by CYP4B1 and the presence of CYP4B1 in bladder mucosa.
    Imaoka S; Yoneda Y; Matsuda T; Degawa M; Fukushima S; Funae Y
    Biochem Pharmacol; 1997 Sep; 54(6):677-83. PubMed ID: 9310344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W
    Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage and repair tests for the detection of genotoxic agents.
    Williams GM
    Food Addit Contam; 1984; 1(2):173-8. PubMed ID: 6536528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.